AstraZeneca to use new vaccine technology to treat cancer, heart disease
London: UK drugmaker AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat cancer, heart conditions and other non-infectious diseases and illnesses. The technology was originally intended for targeting Covid-19, and works by delivering genetic material called self-amplifying...










































